Virus News and Research

Latest Virus News and Research

Genentech, Biogen report Phase III study data of Rituxan in patients with advanced follicular lymphoma

Genentech, Inc., a member of the Roche Group, and Biogen Idec announced today positive data from a Phase III study of Rituxan (rituximab) in patients with advanced follicular lymphoma who did not have symptoms of disease (asymptomatic disease).

6 Dec 2010

Alexion Pharmaceuticals reports interim results from phase 1 trial on samalizumab antibody

Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced the presentation of interim results from the first Phase I/II trial of samalizumab, the company's investigational, first-in-class humanized monoclonal antibody.

6 Dec 2010

Patients with H1N1 flu die due to over-reactive immune response: Research

On November 19, Jason Martin returned to the Medical Intensive Care Unit at Vanderbilt University Medical Center for the first time since he nearly died there during last year's H1N1 flu pandemic. The tall and burly Warren County, TN, ambulance worker - a 30-year-old, father of three young children - broke down and hugged some of the nurses he recognized.

6 Dec 2010

UIC scientist focuses on potential targets to inhibit malaria transmission

University of Illinois at Chicago researcher Dr. John Quigley will describe a promising new approach to blocking malaria transmission during the American Society of Hematology's annual meeting in Orlando, Fla.

6 Dec 2010

Seasonal light cycles can affect development of babies' specific brain function: Study

The season in which babies are born can have a dramatic and persistent effect on how their biological clocks function.

6 Dec 2010

Wide-scale study of flu vaccine's effectiveness in European children needed

A wide-scale study of the effectiveness of flu vaccine in children is needed in Europe to fully assess the benefits, not only in keeping the kids from getting sick, but limiting the spread of flu to adults.

4 Dec 2010

Health experts discuss how to prepare for future dengue immunization programs

AsiaOne examines how groups are working to prepare policy makers for the availability of a dengue vaccine in the future, following a three-day meeting on the virus held in Singapore this week (Chan, 12/3).

4 Dec 2010

Gene mutation can lead to different mental illnesses when influenced by same environmental factor

Male mice born with a genetic mutation that's believed to make humans more susceptible to schizophrenia develop behaviors that mimic other major psychiatric illnesses when their mothers are exposed to an assault to the immune system while pregnant, according to new Johns Hopkins research.

4 Dec 2010

Research findings could provide breakthrough for development of effective therapies for NSCLC

Research at Virginia Commonwealth University Massey Cancer Center led by Charles E. Chalfant, Ph.D., associate professor of biochemistry and molecular Biology, discovered a previously unknown mechanism in non-small cell lung cancer cells that contributes to their ability to maintain and grow tumors. Narrowing in on this mechanism could provide a breakthrough for the development of effective therapies for NSCLC and other cancers.

4 Dec 2010

EPO upholds Alnylam's Tuschl II 1407044 patent

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the European Patent Office (EPO) has fully upheld its Tuschl II '044 (EP 1407044) patent in oral opposition proceedings held in Munich. Specifically, the originally granted claims of the '044 patent were upheld without any modification and were deemed valid and supported by the EPO.

3 Dec 2010

White House marks World AIDS Day

Commemorating World AIDS Day on Wednesday President Barack Obama called for continuing to fight HIV/AIDS domestically and abroad, Agence France-Presse reports (12/1).

2 Dec 2010

MicroRNA linked to mosquito blood digestion and egg development identified

Each year, dengue fever infects as many as 100 million people while yellow fever is responsible for about 30,000 deaths worldwide. Both diseases are spread by infected female Aedes aegypti mosquitoes, which require vertebrate blood to produce eggs. The blood feeding and the egg development are tightly linked to how the mosquito transmits the disease-causing virus.

2 Dec 2010

Pennsylvania Patient Safety Advisory for 2010 December focusses on tackling norovirus outbreaks

In early 2010, Pennsylvania nursing homes and hospitals reported an increased number of cases of gastrointestinal illness which are consistent with recurring outbreaks of the highly contagious norovirus and norovirus-like illnesses nationwide. With a new norovirus season approaching, the Pennsylvania Patient Safety Authority issues its 2010 December Pennsylvania Patient Safety Advisory with data analysis, guidance and success stories provided by Pennsylvania nursing homes for preventing and controlling the illness.

2 Dec 2010

Scientists find new protein to break-up blood clots in prion diseases

The joy of a juicy hamburger could make a comeback thanks a new discovery by scientists from the University of Kentucky. In a new research report in the December 2010 print issue of The FASEB Journal, scientists found that a protein our body uses to break up blood clots speeds up the progress of prion diseases. This substance, called plasminogen, is a new drug target for prion diseases in both humans and animals.

2 Dec 2010

Anti-retroviral therapy yields 'Lazarus effect': Long-term household investment strategy replaces hopelessness

Two teams of researchers at UC San Diego and other U.S. and African universities and the World Bank have documented significant spillover benefits of a drug therapy to combat AIDS symptoms and a novel prevention strategy that focuses on girls in Sub-Saharan Africa, an area with two-thirds of the world's HIV infections.

2 Dec 2010

Study reveals role of VSV in killing cancer cells through turning off major survival signal

Researchers from Boston University School of Medicine (BUSM) have identified a mechanism by which specific viruses acting as oncolytic agents can enter and kill cancer cells. This finding, which is currently featured in an online edition of the Journal of Virology, could help lead to the development of more targeted treatments against many types of cancer.

2 Dec 2010

Biodiversity degradation may have perverse consequences for emerging pathogens

Habitat destruction and species extinction may lead to an increase in diseases that infect humans and other species, according to a paper in the journal Nature co-authored by a University of Florida ecologist.

2 Dec 2010

AMT, Amgen amend GDNF gene license agreement

Amsterdam Molecular Therapeutics Holding N.V., a leader in the development of gene-based therapies, today announced that it has amended and restated its licensing agreement with Amgen for gene therapy applications incorporating the GDNF (glial cell derived neurotrophic factor) gene, to which Amgen holds rights. Financial terms were not disclosed.

2 Dec 2010

FDA grants 510(k) clearance to Focus Diagnostics Simplexa Flu A/B & RSV test on 3M Integrated Cycler

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has issued 510(k) clearance to the Focus Diagnostics Simplexa Flu A/B & RSV test on the 3M™ Integrated Cycler. The Simplexa test, developed and manufactured by Quest Diagnostics' Focus Diagnostics business, is intended as an aid in the detection and discrimination of influenza A, influenza B and RSV virus infections.

From Quest Diagnostics 2 Dec 2010

More effective treatment for severe form of influenza

Flu season is upon us and while getting the nasty bug is bad news, the good news is it's now possible to treat the severe form of the virus more effectively, according to a Ryerson University researcher. Though Canada is not expecting a pandemic flu season this winter Health Canada reports that about 4,000 to 8,000 Canadians die each year from flu-related pneumonia.

2 Dec 2010

Virus News and Research

Latest Virus News and Research

Genentech, Biogen report Phase III study data of Rituxan in patients with advanced follicular lymphoma

Alexion Pharmaceuticals reports interim results from phase 1 trial on samalizumab antibody

Patients with H1N1 flu die due to over-reactive immune response: Research

UIC scientist focuses on potential targets to inhibit malaria transmission

Seasonal light cycles can affect development of babies' specific brain function: Study

Wide-scale study of flu vaccine's effectiveness in European children needed

Health experts discuss how to prepare for future dengue immunization programs

Gene mutation can lead to different mental illnesses when influenced by same environmental factor

Research findings could provide breakthrough for development of effective therapies for NSCLC

EPO upholds Alnylam's Tuschl II 1407044 patent

White House marks World AIDS Day

MicroRNA linked to mosquito blood digestion and egg development identified

Pennsylvania Patient Safety Advisory for 2010 December focusses on tackling norovirus outbreaks

Scientists find new protein to break-up blood clots in prion diseases

Anti-retroviral therapy yields 'Lazarus effect': Long-term household investment strategy replaces hopelessness

Study reveals role of VSV in killing cancer cells through turning off major survival signal

Biodiversity degradation may have perverse consequences for emerging pathogens

AMT, Amgen amend GDNF gene license agreement

FDA grants 510(k) clearance to Focus Diagnostics Simplexa Flu A/B & RSV test on 3M Integrated Cycler

More effective treatment for severe form of influenza

A new way of characterising biomolecules eBook

This International Women’s Day, Meet the Scientist Changing Women’s Healthcare

Microphysiological systems in drug discovery

Considerations for taking ASO discovery programs into animal models

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

This International Women’s Day, Meet the Scientist Changing Women’s Healthcare

Microphysiological systems in drug discovery

Considerations for taking ASO discovery programs into animal models

Newsletters you may be interested in